Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Although the properties of digitalis extracts have been known since the dark ages, their cardiac effects were discovered by the Scottish doctor William Withering in 1776. According to the history, during the treatment of one of his patients, who had a severe heart condition to which no treatment was available at that time. As a last resource, the patient went to a local gypsy, who gave him a secret plant extract, which improved his condition considerably. Intrigued by the fact, Dr. Withering met the gypsy, who revealed that the active ingredient of her potion was an extract of a foxglove plant. Currently, digoxin is on the World Health Organization’s List of Essential Medicines.
This report contains market size and forecasts of Lanoxin API in global, including the following market information:
Global Lanoxin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lanoxin API Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Lanoxin API companies in 2021 (%)
The global Lanoxin API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity: ≥98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lanoxin API include C2 Pharma, Alkaloids Corporation, Vital Labs and Alchem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lanoxin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lanoxin API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Lanoxin API Market Segment Percentages, by Type, 2021 (%)
Purity: ≥98%
Purity: <98%
Global Lanoxin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Lanoxin API Market Segment Percentages, by Application, 2021 (%)
Tablet Product
Injection Product
Global Lanoxin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Lanoxin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lanoxin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lanoxin API revenues share in global market, 2021 (%)
Key companies Lanoxin API sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Lanoxin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem